X4 Pharmaceuticals Inc (NAS:XFOR)
$ 0.393 0.0036 (0.92%) Market Cap: 67.03 Mil Enterprise Value: 10.25 Mil PE Ratio: 0 PB Ratio: 1.11 GF Score: 30/100

Q2 2020 X4 Pharmaceuticals Inc Earnings Call Transcript

Jul 30, 2020 / 12:30PM GMT
Release Date Price: $7.73 (-3.50%)
Operator

Greetings and welcome to X4 Pharmaceuticals Second Quarter Financial Results and Operating Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. As a reminder, this conference call is being recorded.

It is now my pleasure to introduce your host, Candice Ellis, Director of Corporate Communications and Investor Relations at X4. You may begin.

Candice Ellis
X4 Pharmaceuticals - Director, Corporate Communications & IR

Thank you, operator, and good morning everyone. Thanks so much for joining us. Presenting on today's call will be our Chief Executive Officer, Dr. Paula Ragan and our Chief Financial Officer, Adam Mostafa. Following prepared remarks by each, we'll open the call to your questions and they will be joined by our Chief Scientific Officer, Renato Skerlj and our Senior Vice President of Technical Operations and Quality, Mary Dibiase.

As a reminder on today's call, we'll be making forward-looking statements regarding our regulatory and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot